205 related articles for article (PubMed ID: 38607011)
1. Glycerol Trinitrate Acts Downstream of Calcitonin Gene-Related Peptide in Trigeminal Nociception-Evidence from Rodent Experiments with Anti-CGRP Antibody Fremanezumab.
Benedicter N; Vogler B; Kuhn A; Schramm J; Mackenzie KD; Stratton J; Dux M; Messlinger K
Cells; 2024 Mar; 13(7):. PubMed ID: 38607011
[TBL] [Abstract][Full Text] [Related]
2. The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow.
Dux M; Vogler B; Kuhn A; Mackenzie KD; Stratton J; Messlinger K
Cells; 2022 May; 11(11):. PubMed ID: 35681463
[TBL] [Abstract][Full Text] [Related]
3. The Anti-Calcitonin Gene-Related Peptide (Anti-CGRP) Antibody Fremanezumab Reduces Trigeminal Neurons Immunoreactive to CGRP and CGRP Receptor Components in Rats.
Vogler B; Kuhn A; Mackenzie KD; Stratton J; Dux M; Messlinger K
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686275
[TBL] [Abstract][Full Text] [Related]
4. Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment.
Seiler K; Nusser JI; Lennerz JK; Neuhuber WL; Messlinger K
J Headache Pain; 2013 Sep; 14(1):74. PubMed ID: 24004534
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase, calcitonin gene-related peptide and NK-1 receptor mechanisms are involved in GTN-induced neuronal activation.
Ramachandran R; Bhatt DK; Ploug KB; Hay-Schmidt A; Jansen-Olesen I; Gupta S; Olesen J
Cephalalgia; 2014 Feb; 34(2):136-47. PubMed ID: 24000375
[TBL] [Abstract][Full Text] [Related]
6. Semi-Automated Recording of Facial Sensitivity in Rat Demonstrates Antinociceptive Effects of the Anti-CGRP Antibody Fremanezumab.
Benedicter N; Messlinger K; Vogler B; Mackenzie KD; Stratton J; Friedrich N; Dux M
Neurol Int; 2023 Apr; 15(2):622-637. PubMed ID: 37218978
[TBL] [Abstract][Full Text] [Related]
7. Salmon calcitonin ameliorates migraine pain through modulation of CGRP release and dural mast cell degranulation in rats.
Kilinc E; Dagistan Y; Kukner A; Yilmaz B; Agus S; Soyler G; Tore F
Clin Exp Pharmacol Physiol; 2018 Jun; 45(6):536-546. PubMed ID: 29344989
[TBL] [Abstract][Full Text] [Related]
8. Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine.
Kopruszinski CM; Thornton P; Arnold J; Newton P; Lowne D; Navratilova E; Swiokla J; Dodick DW; Dobson C; Gurrell I; Chessell IP; Porreca F
Cephalalgia; 2020 Dec; 40(14):1535-1550. PubMed ID: 33131305
[TBL] [Abstract][Full Text] [Related]
9. Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody.
Melo-Carrillo A; Noseda R; Nir RR; Schain AJ; Stratton J; Strassman AM; Burstein R
J Neurosci; 2017 Jul; 37(30):7149-7163. PubMed ID: 28642283
[TBL] [Abstract][Full Text] [Related]
10. Glyceroltrinitrate facilitates stimulated CGRP release but not gene expression of CGRP or its receptor components in rat trigeminal ganglia.
Eberhardt M; Neeb L; Vogel EM; Tiegs G; Reuter U; Messlinger K; Fischer MJ
Neuropeptides; 2009 Dec; 43(6):483-9. PubMed ID: 19864020
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone Inhibits Neurogenic Inflammation Underlying Migraine Through Modulation of Calcitonin Gene-Related Peptide Release and Stabilization of Meningeal Mast Cells in Glyceryltrinitrate-Induced Migraine Model in Rats.
Kilinc E; Tore F; Dagistan Y; Bugdayci G
Inflammation; 2020 Feb; 43(1):264-273. PubMed ID: 31707574
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-1 inhibits nitroglycerin-induced trigeminal activation of oxidative stress, calcitonin gene-related peptide and c-Fos expression.
Won L; Kraig RP
Neurosci Lett; 2021 Apr; 751():135809. PubMed ID: 33713748
[TBL] [Abstract][Full Text] [Related]
13. Correlation between algogenic effects of calcitonin-gene-related peptide (CGRP) and activation of trigeminal vascular system, in an in vivo experimental model of nitroglycerin-induced sensitization.
Capuano A; Greco MC; Navarra P; Tringali G
Eur J Pharmacol; 2014 Oct; 740():97-102. PubMed ID: 24998872
[TBL] [Abstract][Full Text] [Related]
14. Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain.
Christensen SL; Petersen S; Kristensen DM; Olesen J; Munro G
Cephalalgia; 2019 Dec; 39(14):1827-1837. PubMed ID: 31288556
[TBL] [Abstract][Full Text] [Related]
15. Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors.
Melo-Carrillo A; Strassman AM; Nir RR; Schain AJ; Noseda R; Stratton J; Burstein R
J Neurosci; 2017 Nov; 37(44):10587-10596. PubMed ID: 28972120
[TBL] [Abstract][Full Text] [Related]
16. Characteristics associated with response to subcutaneously administered anti-CGRP monoclonal antibody medications in a real-world community cohort of persons living with migraine: A retrospective clinical and genetic study.
Chase BA; Semenov I; Rubin S; Meyers S; Mark A; Makhlouf T; Chirayil TT; Maraganore D; Wei J; Zheng SL; Xu J; Epshteyn A; Pham A; Frigerio R; Markopoulou K
Headache; 2024 Jan; 64(1):68-92. PubMed ID: 38071464
[TBL] [Abstract][Full Text] [Related]
17. Anti-CGRP antibody galcanezumab modifies the function of the trigeminovascular nocisensor complex in the rat.
Friedrich N; Németh K; Tanner M; Rosta J; Dobos I; Oszlács O; Jancsó G; Messlinger K; Dux M
J Headache Pain; 2024 Jan; 25(1):9. PubMed ID: 38243174
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in behavior and expression of CGRP-related genes in a rodent model of chronic migraine.
Stucky NL; Gregory E; Winter MK; He YY; Hamilton ES; McCarson KE; Berman NE
Headache; 2011 May; 51(5):674-92. PubMed ID: 21521205
[TBL] [Abstract][Full Text] [Related]
19. Effect of a calcitonin gene-related peptide-binding L-RNA aptamer on neuronal activity in the rat spinal trigeminal nucleus.
Fischer MJM; Schmidt J; Koulchitsky S; Klussmann S; Vater A; Messlinger K
J Headache Pain; 2018 Jan; 19(1):3. PubMed ID: 29335794
[TBL] [Abstract][Full Text] [Related]
20. The calcitonin gene-related peptide receptor antagonist MK-8825 decreases spinal trigeminal activity during nitroglycerin infusion.
Feistel S; Albrecht S; Messlinger K
J Headache Pain; 2013 Nov; 14(1):93. PubMed ID: 24256609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
